Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial
Belantamab mafodotin、泊马度胺和地塞米松治疗难治性多发性骨髓瘤:一项 1/2 期试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-023-02703-y
Trudel, Suzanne; McCurdy, Arleigh; Louzada, Martha L; Parkin, Stephen; White, Darrell; Chu, Michael P; Kotb, Rami; Mian, Hira; Othman, Ibraheem; Su, Jiandong; Khan, Aniba; Gul, Engin; Reece, Donna